JP2024516402A5 - - Google Patents
Info
- Publication number
- JP2024516402A5 JP2024516402A5 JP2023565617A JP2023565617A JP2024516402A5 JP 2024516402 A5 JP2024516402 A5 JP 2024516402A5 JP 2023565617 A JP2023565617 A JP 2023565617A JP 2023565617 A JP2023565617 A JP 2023565617A JP 2024516402 A5 JP2024516402 A5 JP 2024516402A5
- Authority
- JP
- Japan
- Prior art keywords
- fibroblasts
- cells
- endothelial progenitor
- transfection
- cultured
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163184960P | 2021-05-06 | 2021-05-06 | |
| US63/184,960 | 2021-05-06 | ||
| PCT/US2022/028082 WO2022236063A1 (en) | 2021-05-06 | 2022-05-06 | Induction of tumor vascular necrosis utilizing fibroblasts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516402A JP2024516402A (ja) | 2024-04-15 |
| JP2024516402A5 true JP2024516402A5 (https=) | 2025-05-02 |
Family
ID=83901050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565617A Pending JP2024516402A (ja) | 2021-05-06 | 2022-05-06 | 線維芽細胞を利用した腫瘍血管壊死の誘導 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220354898A1 (https=) |
| EP (1) | EP4333862A4 (https=) |
| JP (1) | JP2024516402A (https=) |
| AU (1) | AU2022271291A1 (https=) |
| CA (1) | CA3217027A1 (https=) |
| WO (1) | WO2022236063A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2467557A1 (en) * | 2001-11-19 | 2003-05-30 | Kyowa Hakko Kogyo Co., Ltd. | Agent which mobilizes multipotential stem cells from tissues to peripheral blood |
| DE10338733A1 (de) * | 2003-08-22 | 2005-03-24 | Berdel, Wolfgang E., Prof. Dr.med. | Fusionspolypeptide und deren Verwendung für die antivaskuläre Tumortherapie |
| WO2011030332A2 (en) * | 2009-09-08 | 2011-03-17 | Yeda Research And Development Co. Ltd. | Methods for hematopoietic precursor mobilization |
| KR20190096414A (ko) * | 2016-12-22 | 2019-08-19 | 오하이오 스테이트 이노베이션 파운데이션 | 체세포를 유도된 혈관형성 세포로 재프로그래밍하기 위한 조성물 및 방법 |
| US20190352601A1 (en) * | 2017-02-01 | 2019-11-21 | Cornell University | Engineering blood vessel cells for transplantation |
| EP3810159B1 (en) * | 2018-05-04 | 2024-10-16 | FibroBiologics, Inc. | Fibroblast delivery of tumor inhibitory agents |
| AU2020284114B2 (en) * | 2019-05-31 | 2025-06-26 | Fibrobiologics, Inc. | Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis |
| US20220387516A1 (en) * | 2019-11-02 | 2022-12-08 | Figene, Llc | Fibroblast-derived universal immunological composition |
-
2022
- 2022-05-06 JP JP2023565617A patent/JP2024516402A/ja active Pending
- 2022-05-06 WO PCT/US2022/028082 patent/WO2022236063A1/en not_active Ceased
- 2022-05-06 EP EP22799683.2A patent/EP4333862A4/en active Pending
- 2022-05-06 US US17/738,584 patent/US20220354898A1/en active Pending
- 2022-05-06 CA CA3217027A patent/CA3217027A1/en active Pending
- 2022-05-06 AU AU2022271291A patent/AU2022271291A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2361611C2 (ru) | Конструирование рекомбинанта онколитического аденовируса, специфически экспрессирующего иммуномодуляторный фактор gm-csf в опухолевых клетках, и его применение | |
| Ilan et al. | Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats. | |
| Schultz et al. | Long-lasting anti-metastatic efficiency of interleukin 12-encoding plasmid DNA | |
| De Gruijl et al. | Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors | |
| BG106028A (bg) | Имунотерапия на рак чрез експресия на скъсен туморен или тумор-асоцииран антиген | |
| JP5588990B2 (ja) | 機械的表皮破壊を介したポックスウイルスベクターによるワクチン接種 | |
| JP2004536615A (ja) | 抗原提示細胞、その調製方法およびその癌ワクチンのための使用 | |
| JP2002502228A (ja) | 細胞サイクルによって制御される細胞に特異的な活性化合物を用いる、免疫系に関連した疾病の遺伝子療法 | |
| JP2023506707A5 (https=) | ||
| CN111630159A (zh) | 重组腺病毒及包含此病毒的干细胞 | |
| Hargadon | Murine and human model systems for the study of dendritic cell immunobiology | |
| CN114480505A (zh) | 间充质干细胞及其抗炎应用 | |
| US20060073123A1 (en) | Adenovirus vectors for immunotherapy | |
| WO2022018884A1 (ja) | 栄養障害型表皮水疱症の治療薬 | |
| JP2024516402A5 (https=) | ||
| Tenbusch et al. | Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity | |
| Harui et al. | Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL | |
| JP4554940B2 (ja) | ヒト胎盤由来の間葉系細胞を含む医薬及び該細胞を用いたｖｅｇｆの製造方法 | |
| Yang et al. | Improvement of dendritic-based vaccine efficacy against hepatitis B virus–related hepatocellular carcinoma by two tumor-associated antigen gene–infected dendritic cells | |
| AU2005282384B2 (en) | Conditioned medium of autologous or allogenic progenitor cells for angiogenesis treatment | |
| JPH10506289A (ja) | ２の治療的遺伝子：自殺性および免疫刺激性遺伝子を含むアデノウイルス | |
| EP1097714A1 (fr) | Composition pour le traitement de tumeurs et l'immunisation d'organismes à l' encontre de tumeurs | |
| Santos et al. | Spatial and temporal expression of herpes simplex virus type 1 amplicon-encoded genes: implications for their use as immunization vectors | |
| US20060057722A1 (en) | Conditioned medium of autologous or allogenic progenitor cells for angiogenesis treatment | |
| AU717974B2 (en) | Transduced human hematopoietic stem cells |